Evidence map›Paper›PMID 26765121›Full record

ArticleScientific reports2016

Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8(+) T Lymphocyte Fates.

Patrick J Metz, Justine Lopez, Stephanie H Kim, Kazunori Akimoto, Shigeo Ohno, John T Chang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Epigenetics · 2022
    Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Patrick J MetzDepartment of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
Justine LopezDepartment of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
Stephanie H KimDepartment of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
Kazunori AkimotoDepartment of Molecular Biology, Yokohama City University School of Medicine, Kanazawa, Yokohama, Kanagawa Prefecture 236-0027, Japan.
Shigeo OhnoDepartment of Molecular Biology, Yokohama City University School of Medicine, Kanazawa, Yokohama, Kanagawa Prefecture 236-0027, Japan.
John T ChangDepartment of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
University of California, San Diego · USYokohama City University · JP

Funding

U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
Training Grant in GastroenterologyT32DK007202 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 1985 to 2022
$7.7M
The UCSD Digestive Diseases Research Development CenterR24DK080506 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ECKMANN, LARS · 2008 to 2012
$2.7M
Regulation and Function of Polarity and Asymmetric Cell Division in ImmunityR01AI095277 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, JOHN T · 2012 to 2016
$2.6M
Understanding the Basis for Cellular Diversity During Adaptive ImmunityDP2OD008469 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, JOHN T · 2011 to 2011
$2.3M
Role of atypical Protein Kinase C in Inflammatory Bowel DiseaseR01DK093507 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, JOHN T · 2012 to 2016
$1.7M
Asymmetric T cell division initiating adaptive immunity and colitisK08DK080949 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI CHANG, JOHN T · 2008 to 2012
$723k
Howard Hughes Medical InstituteNIAID NIH HHS AI095277NIAID NIH HHS R01 AI095277NIDDK NIH HHS DK080949NIDDK NIH HHS DK80506NIDDK NIH HHS K08 DK080949NIDDK NIH HHS R01 DK093507NIDDK NIH HHS R24 DK080506NIDDK NIH HHS T32 DK007202NIH HHS DP2 OD008469NIH HHS OD008469NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

Naïve CD8(+) T lymphocytes responding to microbial pathogens give rise to effector T cells that provide acute defense and memory T cells that provide long-lived immunity. Upon activation, CD8(+) T lymphocytes can undergo asymmetric division, unequally distributing factors to the nascent daughter cells that influence their eventual fate towards the effector or memory lineages. Individual loss of either atypical protein kinase C (aPKC) isoform, PKCζ or PKCλ/ι, partially impairs asymmetric divisions and increases CD8(+) T lymphocyte differentiation toward a long-lived effector fate at the expense of memory T cell formation. Here, we show that deletion of both aPKC isoforms resulted in a deficit in asymmetric divisions, increasing the proportion of daughter cells that inherit high amounts of effector fate-associated molecules, IL-2Rα, T-bet, IFNγR, and interferon regulatory factor 4 (IRF4). However, unlike CD8(+) T cells deficient in only one aPKC isoform, complete loss of aPKC unexpectedly increased CD8(+) T cell differentiation toward a short-lived, terminal effector fate, as evidenced by increased rates of apoptosis and decreased expression of Eomes and Bcl2 early during the immune response. Together, these results provide evidence for an important role for asymmetric division in CD8(+) T lymphocyte fate specification by regulating the balance between effector and memory precursors at the initiation of the adaptive immune response.

Indexed as

Asymmetric Cell DivisionCell DifferentiationAdaptive ImmunityAnimalsCD8-Positive T-LymphocytesGene Knockout TechniquesImmunologic MemoryLymphocyte ActivationMiceProtein Kinase CT-Lymphocyte SubsetsProtein Kinase C

Identifiers

PMID26765121
PMCPMC4725917
OpenAlexW2411123281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.